Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
840 participants
OBSERVATIONAL
2009-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand
NCT00162682
A Sub-study of PREDICT Neurodevelopment Protocol
NCT02406768
Chinese Network of Pediatric Antiretroviral Therapy
NCT01210924
Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
NCT01511237
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
NCT05154513
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
long-term follow-up of HIV-infected children
standard ART according to the Thai Ministry of Public Health national guidelines
Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard ART according to the Thai Ministry of Public Health national guidelines
Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR)
3. Signed consent form
Exclusion Criteria
2. Emergency case
3. Incomplete Medical Record
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bamrasnaradura Infectious Diseases Institute
OTHER_GOV
Mahidol University
OTHER
Chiangrai Prachanukroh Hospital
OTHER
Sanpatong Hospital
UNKNOWN
The HIV Netherlands Australia Thailand Research Collaboration
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wisit Prasithsirikul, MD
Role: PRINCIPAL_INVESTIGATOR
Bamrasnaradura infectious disease institute
Rawiwan Hansudewechakul, MD
Role: PRINCIPAL_INVESTIGATOR
Chiangrai Prachanukroh Hospital
Wirat Klinbuayam, MD
Role: PRINCIPAL_INVESTIGATOR
Sanpatong Hospital
Jintanat Ananworanich, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
HIV-NAT, Thai Red Cross - AIDS Research Centre
Kulkanya Chokephaibulkit, MD
Role: PRINCIPAL_INVESTIGATOR
Mahidol University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chiangrai Prachanukroh Hospital
Chiang Rai, Changwat Chiang Rai, Thailand
Bamrasnaradura infectious disease institute
Nonthaburi, Changwat Nonthaburi, Thailand
Sanpatong Hospital
Sanpathong, Chiang Mai, Thailand
HIV-NAT, Thai Red Cross AIDS Research Centre
Bangkok, , Thailand
Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bunupuradah T, Sricharoenchai S, Hansudewechakul R, Klinbuayaem V, Teeraananchai S, Wittawatmongkol O, Akarathum N, Prasithsirikul W, Ananworanich J; Pediatric PROGRESS Study Team. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents. Pediatr Infect Dis J. 2015 Mar;34(3):e58-62. doi: 10.1097/INF.0000000000000584.
Related Links
Access external resources that provide additional context or updates about the study.
HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIV-NAT 154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.